NASDAQ · SAMA
Schultze Special Purpose Acquisition Corp. II
$10.58-$0.06 (-0.53%)
Schultze Special Purpose Acquisition Corp. II’s quoted price sits in the lower half of its reported 52-week range, 10.34% below the high.
Loading market information…
NASDAQ · DECA · USD
Stock price, dividends, earnings
Quote as of Mar 9, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Denali Capital Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 13.41% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Denali Capital Acquisition Corp.’s forward annual dividend is $0.28 per share, paid quarterly. The forward yield is 2.45% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Denali Capital Acquisition Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Denali Capital Acquisition Corp., established in New York City in 2022, primarily aims to complete a strategic business combination. This could take various forms, such as a merger, asset acquisition, share exchange, or corporate reorganization, involving one or more enterprises. The company specifically targets opportunities within the technology, consumer, and hospitality sectors.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:43 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$10.58-$0.06 (-0.53%)
Schultze Special Purpose Acquisition Corp. II’s quoted price sits in the lower half of its reported 52-week range, 10.34% below the high.
$4.74$0.00 (0.0%)
Prospector Capital Corp.’s quoted price sits in the lower half of its reported 52-week range, 1.46% below the high.
$12.03-$0.07 (-0.58%)
Ace Global Business Acquisition Limited’s quoted price sits in the upper half of its reported 52-week range, 1.64% below the high.
$12.00+$2.00 (+20.0%)
Western Acquisition Ventures Corp.’s quoted price sits in the lower half of its reported 52-week range, 82.4% below the high.
$10.81-$0.30 (-2.7%)
TG Venture Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 7.13% below the high.
$10.92-$0.03 (-0.23%)
Fat Projects Acquisition Corp’s quoted price sits in the lower half of its reported 52-week range, 15.32% below the high.
$9.46-$1.50 (-13.69%)
Moringa Acquisition Corp’s quoted price sits in the lower half of its reported 52-week range, 30.22% below the high.
$5.85+$0.37 (+6.75%)
Phoenix Biotech Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 54.3% below the high.
